A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
Clinical trial NCT02962960 · COMPLETED
Trial details
- NCT number
- NCT02962960
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2018-01-22
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.